Literature DB >> 15605854

Palliative irradiation of Scottish Fold osteochondrodysplasia.

Madeleine Hubler1, Mathias Volkert, Barbara Kaser-Hotz, Susi Arnold.   

Abstract

This report describes palliative irradiation as treatment for Scottish Fold osteochondrodysplasia. A 3-year-old female spayed Scottish Fold cat suffering from osteochondrodysplasia was referred to the Veterinary Teaching Hospital, University of Zurich. Based on the breed, history, clinical signs, radiographic findings, and the histologic diagnosis of a biopsy specimen, Scottish Fold osteochondrodysplasia was confirmed. To control the exostoses leading to inflammatory processes and pain, radiotherapy was initiated as palliative treatment. This was successful in relieving the clinical signs within a few weeks. The short- and long-term results after radiotherapy are presented and discussed with a comparable human disease, the plantar heel spur, which also responds well to radiotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15605854     DOI: 10.1111/j.1740-8261.2004.04101.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  4 in total

1.  Osteochondrodysplasia in three Scottish Fold cats.

Authors:  Jinhwa Chang; Joohyun Jung; Sunkyoung Oh; Sungok Lee; Gyeongmin Kim; Haksang Kim; Ohkyeong Kweon; Junghee Yoon; Mincheol Choi
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

Review 2.  The old and new face of craniofacial research: How animal models inform human craniofacial genetic and clinical data.

Authors:  Eric Van Otterloo; Trevor Williams; Kristin Bruk Artinger
Journal:  Dev Biol       Date:  2016-01-22       Impact factor: 3.582

3.  Osteochondrodysplasia in Scottish Fold cross-breed cats.

Authors:  Masamine Takanosu; Yuki Hattori
Journal:  J Vet Med Sci       Date:  2020-11-06       Impact factor: 1.267

4.  Efficacy and Complications of Palliative Irradiation in Three Scottish Fold Cats with Osteochondrodysplasia.

Authors:  A Fujiwara-Igarashi; H Igarashi; D Hasegawa; M Fujita
Journal:  J Vet Intern Med       Date:  2015-09-14       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.